Dr. Meghan Lewis, MD
Claim this profileStudies Intestinal Pseudo-Obstruction
Studies Acute colonic pseudo-obstruction
1 reported clinical trial
1 drug studied
More about Meghan Lewis, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Meghan Lewis, MD has experience with
- Neostigmine
Breakdown of trials Meghan Lewis, MD has run
Intestinal Pseudo-Obstruction
Acute colonic pseudo-obstruction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Meghan Lewis, MD specialize in?
Meghan Lewis, MD focuses on Intestinal Pseudo-Obstruction and Acute colonic pseudo-obstruction. In particular, much of their work with Intestinal Pseudo-Obstruction has involved treating patients, or patients who are undergoing treatment.
Is Meghan Lewis, MD currently recruiting for clinical trials?
No, Meghan Lewis, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Meghan Lewis, MD has studied deeply?
Yes, Meghan Lewis, MD has studied treatments such as Neostigmine.
What is the best way to schedule an appointment with Meghan Lewis, MD?
Apply for one of the trials that Meghan Lewis, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.